Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 9
370
Views
8
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

The effects of UDP-sugars, UDP and Mg2+on uridine diphosphate glucuronosyltransferase activity in human liver microsomes

, , , &
Pages 882-890 | Received 14 Jul 2017, Accepted 02 Sep 2017, Published online: 26 Sep 2017

References

  • Abe N, Abe E, Yuasa A. (1992). An improved assay method for UDP-glucuronyltransferase activity towards 5-hydroxytryptamine and the characteristic properties of the enzyme. J Vet Med Sci 54:125–30.
  • Argikar UA, Remmel RP. (2009). Variation in glucuronidation of lamotrigine in human liver microsomes. Xenobiotica 39:355–63.
  • Bedford CT, Hickman AD, Logan CJ. (2003). Structure-activity studies of glucose transfer: determination of the spontaneous rates of hydrolysis of uridine 5′-diphospho-alpha-D-glucose (UDPG) and uridine 5′-diphospho-alpha-D-glucuronic acid (UDPGA). Bioorg Med Chem 11:2339–45.
  • Boase S, Miners JO. (2002). In vitro–in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. Br J Clin Pharmacol 54:493–503.
  • Bosio A, Binczek E, LeBeau MM, et al. (1996). The human gene CGT encoding the UDP-galactose ceramide calactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34:69–75.
  • Bossuyt X, Blanckaert N. (1995). Mechanism of stimulation of microsomal UDP-glucuronosyltransferase by UDP-N-acetylglucosamine. Biochem J 305:321–8.
  • Bossuyt X, Blanckaert N. (1996). Uridine diphosphoxylose enhances hepatic microsomal UDP-glucuronosyltransferase activity by stimulating transport of UDP-glucuronic acid across the endoplasmic reticulum membrane. Biochem J 315:189–93.
  • Bushee JL, Liang GQ, Dunne CE, et al. (2014). Identification of saturated and unsaturated fatty acids released during microsomal incubations. Xenobiotica 44:687–95.
  • Chen SJ, Beaton D, Nguyen N, et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–57.
  • Collier AC, Tingle MD, Keelan JA, et al. (2000). A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metab Dispos 28:1184–6.
  • Coughtrie MWH, Blair JNR, Hume R, Burchell A. (1991). Improved preparation of hepatic microsomes for in vitro diagnosis of inherited disorders of the glucose-6-phosphatase system. Clin Chem 37:739–42.
  • Fang M, Shen ZR, Huang S, et al. (2010). The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143:711–24.
  • Farkas E, Szabo O, Tircso G, Somsak L. (2013). Relaxometric determination of binding between Mn(II)-UDP and Mn(II)-UDP-glucose in aqueous solution. Carbohydr Res 368:68–72.
  • Fisher MB, Campanale K, Ackermann BL, et al. (2000). In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560–6.
  • Fujiwara R, Nakajima M, Yamanaka H, et al. (2008). Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. Drug Metab Dispos 36:361–7.
  • Goto S, Taniguchi M, Muraoka M, et al. (2001). UDP-sugar transporter implicated in glycosylation and processing of Notch. Nat Cell Biol 3:816–22.
  • Hadley B, Maggioni A, Ashikov A, et al. (2014). Structure and function of nucleotide sugar transporters: current progress. Comput Struct Biotech J 10:23–32.
  • Ishida N, Kawakita M. (2004). Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch 447:768–75.
  • Ishii Y, An K, Nishimura Y, Yamada H. (2012). ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT. Drug Metab Dispos 40:2081–9.
  • Kobayashi T, Sleeman JE, Coughtrie MWH, Burchell B. (2006). Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family. Biochem J 400:281–9.
  • Krishnaswamy S, Duan SX, von Moltke LL, et al. (2003). Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences. Xenobiotica 33:169–80.
  • Ladd MA, Fitzsimmons PN, Nichols JW. (2016). Optimization of a UDP-glucuronosyltransferase assay for trout liver S9 fractions: activity enhancement by alamethicin, a pore-forming peptide. Xenobiotica 46:1066–75.
  • Lin JH, Wong BK. (2002). Complexities of glucuronidation affecting in vitro–in vivo extrapolation. Curr Drug Metab 3:623–46.
  • Luukkanen L, Taskinen J, Kurkela M, et al. (2005). Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 33:1017–26.
  • Mackenzie PI, Bock KW, Burchell B, et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–85.
  • Mackenzie PI, Rogers A, Elliot DJ, et al. (2011). The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. Mol Pharmacol 79:472–8.
  • Mackenzie PI, Rogers A, Treloar J, et al. (2008). Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. J Biol Chem 283:36205–10.
  • Manevski N, Yli-Kauhaluoma J, Finel M. (2012). UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albumin. Drug Metab Dispos 40:2192–203.
  • Meech R, Mackenzie PI. (2010). UGT3A: novel UDP-glycosyltransferases of the UGT superfamily. Drug Metab Rev 42:45–54.
  • Meech R, Mubarokah N, Shivasami A, et al. (2015). A novel function for UDP glycosyltransferase 8: galactosidation of bile acids. Mol Pharmacol 87:442–50.
  • Meech R, Rogers A, Zhuang L, et al. (2012). Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes. J Biol Chem 287:24122–30.
  • Miyagi SJ, Collier AC. (2007). Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos 35:1587–92.
  • Miyagi SJ, Collier AC. (2011). The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. Drug Metab Dispos 39:912–9.
  • Miyagi SJ, Milne AM, Coughtrie MWH, Collier AC. (2012). Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics. Drug Metab Dispos 40:1321–7.
  • Radominska-Pandya A, Czernik PJ, Little JM, et al. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817–99.
  • Rowland A, Knights KM, Mackenzie PI, Miners JO. (2008). The "Albumin Effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities. Drug Metab Dispos 36:1056–62.
  • Rowland A, Miners JO, Mackenzie PI. (2013). The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 45:1121–32.
  • Senekeo-Effenberger K, Chen S, Brace-Sinnokrak E, et al. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419–27.
  • Soars MG, Ring BJ, Wrighton SA. (2003). The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases. Drug Metab Dispos 31:762–7.
  • Trombetta ES, Helenius A. (1999). Glycoprotein reglucosylation and nucleotide sugar utilization in the secretory pathway: identification of a nucleoside diphosphatase in the endoplasmic reticulum. EMBO J 18:3282–92.
  • Uchaipichat V, Mackenzie PI, Guo XH, et al. (2004). Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32:413–23.
  • Walsky RL, Bauman JN, Bourcier K, et al. (2012). Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. Drug Metab Dispos 40:1051–65.
  • Winsnes A. (1972). Inhibition of hepatic UDP-glucuronyl transferase by nucleotides. Biochim Biophys Acta 289:88
  • Yamamura N, Imura-Miyoshi K, Naganuma H. (2000). Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats. Drug Metab Dispos 28:1484–6.
  • Zakim D, Goldenberg J, Vessey DA. (1973). Kinetic properties of microsomal UDP-glucuronyltransferase – regulation by metal ions. Biochem Biophys Res Commun 52:453–8.
  • Zhou J, Miners JO. (2014). Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs). Methods Mol Biol 1113:203–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.